January is Alzheimer's Awareness Month in Canada. According to the Alzheimer's Association, almost 750,000 Canadians are ...

LATE is a prevalent condition in late life and can contribute to memory loss and cognitive decline, according to report ...

We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...

Yet despite decades of research, no treatment has been created that arrests Alzheimer’s cognitive deterioration, let alone ...

Seasonal affective disorder (SAD) is a type of recurrent depressive periods that occur during the same season each year. SAD ...

Alzheimer's disease is the most common type of dementia. Here, we break down what to know about this disease, including: What ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

New drug approvals and a federal dementia care pilot program among the year's significant developments, according to the ...

Limbic-predominant age-related TDP-43 encephalopathy (LATE) is a recently characterized form of dementia that is distinct ...

Brain damage caused by dementia can lead to anxiety, fear, and irritability, especially in the evening. This is how ...

Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer’s-related psychosis during the ...

A new diagnostic tool is being developed which could one day allow doctors to diagnose Alzheimer's disease through a simple ...